These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2586725)

  • 1. Effect of intracerebrally injected Corynebacterium parvum on the development and growth of metastatic brain tumor in mice.
    Kennedy JD; Sutton RC; Conley FK
    Neurosurgery; 1989 Nov; 25(5):709-14. PubMed ID: 2586725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intracerebrally injected Corynebacterium parvum on implanted brain tumor in mice.
    Kennedy JD; Conley FK
    J Neurooncol; 1989 May; 7(1):89-101. PubMed ID: 2502606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of C. parvum on growth and induction of intracerebral tumours in mice.
    Osborn DE; Sadler TE; Castro JE
    Br J Cancer; 1977 Apr; 35(4):420-5. PubMed ID: 857825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging in an experimental model of brain tumor immunotherapy.
    Blankenberg F; Conley FK; Sayre J; Enzmann D
    AJNR Am J Neuroradiol; 1991; 12(3):543-8. PubMed ID: 2058511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Corynebacterium parvum and chronic Toxoplasma infection on metastatic brain tumors in mice.
    Conley FK
    J Natl Cancer Inst; 1979 Nov; 63(5):1237-44. PubMed ID: 291750
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of immunomodulation on the fate of tumor cells in the central nervous system and systemic organs of mice. Distribution of [125I]5-Iodo-2'-deoxyuridine-labeled KHT tumor cells after left intracardial injection.
    Conley FK
    J Natl Cancer Inst; 1982 Aug; 69(2):465-73. PubMed ID: 6955547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice.
    Kiya K; Toge T; Harada K; Uozumi T; Hattori T
    Gan; 1981 Jun; 72(3):446-50. PubMed ID: 7319201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of an intracerebral rat brain tumor with Corynebacterium parvum and radiation.
    Douple EB
    Natl Cancer Inst Monogr; 1977 Dec; 46():179-84. PubMed ID: 206836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-induced osteogenic sarcoma of C3H mouse: effects of Corynebacterium parvum and WBI on its natural history and response to irradiation.
    Choi CH; Sedlacek RS; Suit HD
    Eur J Cancer (1965); 1979 Apr; 15(4):433-42. PubMed ID: 285860
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of Corynebacterium parvum treatment of mice with sarcoma growing in normal or irradiated tissue.
    Suit HD; Sedlacek R; Echteler S
    Cancer Res; 1977 Nov; 37(11):4233-4. PubMed ID: 908052
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma.
    Woodruff MF; Dunbar N
    Br J Cancer; 1975 Jul; 32(1):34-41. PubMed ID: 1080671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Corynebacterium parvum on tumor growth in the central nervous system of mice.
    Conley FK; Remington JS
    J Natl Cancer Inst; 1978 Sep; 61(3):827-32. PubMed ID: 278860
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitumor activity of Propionibacterium acnes (Corynebacterium parvum) and isolated cytoplasmic fractions.
    Millman I; Scott AW; Halbherr T
    Cancer Res; 1977 Nov; 37(11):4150-5. PubMed ID: 409491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
    Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
    Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysozyme levels and macrophage content of tumor tissue in C3H mice bearing fibrosarcoma transplants treated by radiation and Corynebacterium parvum.
    Mendiondo O; Suit H; Fixler H
    Int J Radiat Oncol Biol Phys; 1978; 4(9-10):829-34. PubMed ID: 711553
    [No Abstract]   [Full Text] [Related]  

  • 16. Modification of radiation responses of murine tumors by misonidazole (Ro 07-0582), host immune capability, and Corynebacterium parvum.
    Stone HB; Milas L
    J Natl Cancer Inst; 1978 Apr; 60(4):887-93. PubMed ID: 633396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralesional immunotherapy of brain tumors with combined Corynebacterium parvum and recombinant interleukin-2 in mice.
    Conley FK; Adler JR; Duncan JA; Kennedy JD; Sutton RC
    J Natl Cancer Inst; 1990 Aug; 82(16):1340-4. PubMed ID: 2380991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with Corynebacterium parvum: reduced effect in irradiated recipients.
    Peters LJ; McBride WH; Mason KA; Hunter N; Basić I; Milas L
    J Natl Cancer Inst; 1977 Sep; 59(3):881-7. PubMed ID: 330869
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicity of IL-2 and Corynebacterium parvum following direct intracranial injection.
    Sutton RC; Kennedy J; Duncan J; Conley FK
    J Neurooncol; 1989 Sep; 7(3):261-7. PubMed ID: 2795120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of prolonged Corynebacterium parvum and cyclophosphamide administration on the growth of established tumors.
    Fisher B; Wolmark N; Saffer E; Fisher ER
    Cancer; 1975 Jan; 35(1):134-43. PubMed ID: 1109767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.